Data-driven epidemiologic approach to conducting site feasibility for a global phase III tuberculosis vaccine clinical trial.
Saved in:
| Title: | Data-driven epidemiologic approach to conducting site feasibility for a global phase III tuberculosis vaccine clinical trial. |
|---|---|
| Authors: | Mui WL; EpiPointe, Cary, North Carolina, United States of America., Parekh FK; EpiPointe, Cary, North Carolina, United States of America., Tseng AS; EpiPointe, Cary, North Carolina, United States of America., Toro J; FHI Clinical, Durham, North Carolina, United States of America., Craig T; FHI Clinical, Durham, North Carolina, United States of America., Ndugga M; FHI Clinical, Durham, North Carolina, United States of America., Schmidt AC; Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, United States of America., Dagnew AF; Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, United States of America., Penz C; Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, United States of America., Belai G; FHI Clinical, Durham, North Carolina, United States of America. |
| Source: | PLOS global public health [PLOS Glob Public Health] 2023 Nov 08; Vol. 3 (11), pp. e0002544. Date of Electronic Publication: 2023 Nov 08 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 9918283779606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-3375 (Electronic) Linking ISSN: 27673375 NLM ISO Abbreviation: PLOS Glob Public Health Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2767-3375 |
|---|---|
| DOI: | 10.1371/journal.pgph.0002544 |
